Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy
Clinical trial NCT07113977 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07113977
- Sponsor
- Wei Guan
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2028-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.